Jericho Assisted Living
Tuesday, June 14, 2016
Biosimilar Insulin Glargine Matches Up With Lantus in Phase III
(MedPage Today) -- Merck's copycat has similar HbA1c effect in trial
via
Biosimilar Insulin Glargine Matches Up With Lantus in Phase III
by
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment